Argenx Se (ARGX) Current Taxes (2017 - 2025)

Argenx Se (ARGX) posted Current Taxes of $42.2 million for Q4 2025, down 99.77% on a QoQ basis from $18.2 billion in Q2 2025, and up 215.23% year-over-year from $13.4 million in Q4 2024.

Argenx Se (ARGX) Current Taxes (2017 - 2025) Analysis & Trends

Argenx Se's Current Taxes history runs 9 years deep, the most recent figure standing at $42.2 million for Q4 2025.

  • Quarterly Current Taxes rose 215.23% year-over-year to $42.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $42.2 million (up 215.23% YoY) and the FY2025 annual result came in at $42.2 million, up 215.23% from the prior year.
  • Current Taxes was $42.2 million for Q4 2025 at Argenx Se, down from $18.2 billion in the prior quarter.
  • Across five years, Current Taxes topped out at $18.2 billion in Q2 2025 and bottomed at $1.2 million in Q2 2021.
  • A 5-year average of $1.8 billion and a median of $4.5 million in 2023 frame the typical range for Current Taxes.
  • Annual changes were most pronounced in 2022 — Current Taxes fell 26.28% — and 2025, when it surged 130107.21%.
  • Argenx Se's Current Taxes stood at $4.3 million in 2021, then decreased by 26.28% to $3.2 million in 2022, then surged by 36.25% to $4.3 million in 2023, then surged by 208.95% to $13.4 million in 2024, then jumped by 215.23% to $42.2 million in 2025.
  • Business Quant data shows ARGX's Current Taxes at $42.2 million in Q4 2025, $18.2 billion in Q2 2025, and $13.4 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 63.52 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn -
7 Belite Bio 61.40 Bn 61.40 Bn - -
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -
9 Revolution Medicines 37.37 Bn 37.37 Bn - -
10 Alnylam Pharmaceuticals 36.08 Bn 33.07 Bn 959.66 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 42.21 Mn
Jun 30, 2025 18.16 Bn
Dec 31, 2024 13.39 Mn
Jun 30, 2024 13.95 Mn
Dec 31, 2023 4.33 Mn
Jun 30, 2023 4.61 Mn
Dec 31, 2022 3.18 Mn
Jun 30, 2022 3.42 Mn
Dec 31, 2021 4.32 Mn
Jun 30, 2021 1.15 Mn
Dec 31, 2020 3.40 Mn
Jun 30, 2020 474,729.32
Dec 31, 2019 380,769.36
Jun 30, 2019 424,735.58
Dec 31, 2018 939,369.26
Jun 30, 2018 674,296.09
Dec 31, 2017 702,927.22
Jun 30, 2017 656,430.94